Hybrigenics SA ( ALHYG.PA) Stock. Should you Buy or Sell? $ 0.12
0.00 (-3.65 %)
Hybrigenics SA Analysis
Updated on 10-09-2022
Symbol |
ALHYG.PA |
Price |
$0.12 |
Beta |
1.763 |
Volume Avg. |
$791.66 thousand |
Market Cap |
$33.02 M |
52 Week Range |
$0.0923 - $0.202 |
Hybrigenics SA opened the day at $0.12 which is -3.65 % on yesterday's close.
Hybrigenics SA has a 52 week high of $0.202 and 52 week low of $0.0923, which is a difference of $0.1097.
We like to see positive, upward trending shares, preferably with momentum.
Market capitalization is $33.02 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Hybrigenics SA for $33.02 M, it would take 15 years to get your money back. Hybrigenics SA are in the Biotechnology space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
1 D | All
Financials
Hybrigenics SA Stock Forecast - Is Hybrigenics SA a Buy or Sell?
DCF Score | | Strong Buy |
ROE Score | | Strong Sell |
ROA Score | | Strong Sell |
DE Score | | Strong Buy |
PE Score | | Strong Sell |
PB Score | | Strong Buy |
Overall Recommendation | | Neutral |
Growth and Value
PE Ratio |
-2.078 |
Dividend Yiel |
0.000 |
Net Profit Margin |
-12.457 |
Valuing Hybrigenics SA
Price Book Value Ratio |
0.536 |
Price To Book Ratio |
0.536 |
Price To Sales Ratio |
25.880 |
Price Earnings Ratio |
-2.078 |
How liquid is Hybrigenics SA
Current Ratio |
1.208 |
Quick Ratio |
0.414 |
Debt
Debt Ratio |
0.283 |
Debt Equity Ratio |
0.394 |
Long Term Debt To Capitalization |
0.000 |
Total Debt To Capitalization |
0.000 |
Latest news about Hybrigenics SA
About Hybrigenics SA
CEO : Dr. Remi Delansorne
Sector : Healthcare
Industry : Biotechnology
Website : https://www.hybrigenics.com
Description :
Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.